Total planned funding: $1,359,128,654
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $274,802,981 |
Zambia | $224,826,842 |
Tanzania | $219,094,318 |
Mozambique | $137,237,701 |
Kenya | $85,732,779 |
Uganda | $84,713,641 |
Zimbabwe | $76,492,216 |
Democratic Republic of the Congo | $49,704,557 |
Rwanda | $44,611,683 |
Haiti | $33,592,964 |
Ethiopia | $31,821,296 |
Eswatini | $15,065,135 |
Vietnam | $10,874,598 |
Côte d'Ivoire | $10,550,789 |
South Africa | $8,076,885 |
Burundi | $7,799,057 |
West Africa Region | $5,678,527 |
Namibia | $5,286,094 |
Ukraine | $5,248,771 |
Lesotho | $5,054,620 |
Malawi | $4,816,979 |
Cameroon | $4,514,684 |
Angola | $2,764,049 |
Western Hemisphere Region | $2,048,556 |
Asia Regional Program | $1,814,606 |
Botswana | $1,617,948 |
Indonesia | $1,300,000 |
Ghana | $1,010,959 |
Central America Region | $921,400 |
South Sudan | $691,359 |
Caribbean Region | $512,660 |
Burma | $500,000 |
Cambodia | $350,000 |
Organizational Types
Private Contractor | $1,359,128,654 |
Program Areas
Treatment | $1,077,140,278 |
Care | $98,549,546 |
Prevention | $70,909,454 |
Testing | $59,722,682 |
Governance and Systems | $52,806,694 |
Budget Codes
HTXD: Treatment: ARV Drugs | $693,131,374 |
HTXS: Treatment: Adult Treatment | $312,887,071 |
PDTX: Treatment: Pediatric Treatment | $71,121,833 |
HVCT: Testing: HIV Testing and Counseling | $59,722,682 |
OHSS: Health Systems Strengthening | $46,618,234 |
HVTB: Care: TB/HIV | $42,233,685 |
HBHC: Care: Adult Care and Support | $39,095,209 |
HVOP: Sexual Prevention: Other Sexual Prevention | $28,795,474 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $26,827,222 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,362,138 |
HKID: Care: Orphans and Vulnerable Children | $8,794,927 |
PDCS: Care: Pediatric Care and Support | $8,425,725 |
HLAB: Laboratory Infrastructure | $4,147,833 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,392,620 |
HVSI: Strategic Information | $2,040,627 |
HMIN: Biomedical Prevention: Injection Safety | $287,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $245,000 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Chemonics International:
$1,359,128,654
View countries